Dyno Therapeutics Expands Frontiers Network to Accelerate Gene Therapy Development
Trendline

Dyno Therapeutics Expands Frontiers Network to Accelerate Gene Therapy Development

What's Happening? Dyno Therapeutics, an AI-enabled genetic technologies company, has expanded its Dyno Frontiers Network to include new Translational Partners: Aurelix Bio (USA), CoJourney Bio (China), and PrimeRA Pharma Partners (UK, EU, USA). This expansion aims to accelerate the path to clinical
AI Generated
This may include content generated using AI tools. Glance teams are making active and commercially reasonable efforts to moderate all AI generated content. Glance moderation processes are improving however our processes are carried out on a best-effort basis and may not be exhaustive in nature. Glance encourage our users to consume the content judiciously and rely on their own research for accuracy of facts. Glance maintains that all AI generated content here is for entertainment purposes only.